| Patents for A61P 19 - Drugs for skeletal disorders (81,981) |
|---|
| 03/08/2006 | CN1742876A Chinese medicine for treating tractures and preparation for making plaster thereof |
| 03/08/2006 | CN1742872A Lopseed-root medicated liquor |
| 03/08/2006 | CN1742871A Gamboge bone-tonifying preparation and new preparation method thereof |
| 03/08/2006 | CN1742867A Pure Chinese medicine for treating protrasion of lumbar intervertebral disc and osteoporosis and preparation method |
| 03/08/2006 | CN1742858A Blumea lanceolaria fracture medicated liquor |
| 03/08/2006 | CN1742857A Berchemia sinica schneid external-use medicine |
| 03/08/2006 | CN1742856A Radix aconitic kusnezoffii external-use medicine |
| 03/08/2006 | CN1742855A Xiaolongguojiang medicated liquor |
| 03/08/2006 | CN1742852A Medicated lanceolarium Roxb medicated liquor |
| 03/08/2006 | CN1742851A Wuxiangxueteng medicated liquor |
| 03/08/2006 | CN1742850A Medicated liquor of stephania japonica miers |
| 03/08/2006 | CN1742846A External Chinese medicine for treating burn and scald and preparing method |
| 03/08/2006 | CN1742839A Nutritious health-care oral liquor for woman and preparing process |
| 03/08/2006 | CN1742836A Compound lotus plumule oral liquor and preparing method thereof |
| 03/08/2006 | CN1742834A Chinese medicine composition for treating diabets and preparing method |
| 03/08/2006 | CN1742831A External-use Chinese medicine for treating arthritis and preparing method |
| 03/08/2006 | CN1742827A Xunmagen medicated liquor |
| 03/08/2006 | CN1742826A Tiekuaizi medicated liquor |
| 03/08/2006 | CN1742817A Liulingma fracture medicated liquor |
| 03/08/2006 | CN1742816A Wujiaofeng root external-use medicine |
| 03/08/2006 | CN1742815A External-use medicine of lysimachia root |
| 03/08/2006 | CN1742811A Haifengteng fracture medicated liquor |
| 03/08/2006 | CN1742809A Method for preparing xiatianwu injecta |
| 03/08/2006 | CN1742804A Daoshenglian medicated liquor |
| 03/08/2006 | CN1742802A Yizhihao external-use medicine |
| 03/08/2006 | CN1742801A Qianjinba external-use medicine |
| 03/08/2006 | CN1742800A Wuxiangteng medicated liquor |
| 03/08/2006 | CN1742795A Luoshiteng medicated liquor |
| 03/08/2006 | CN1742782A Zhulan medicated liquor |
| 03/08/2006 | CN1742780A Tuqiannianjian medicated liquor |
| 03/08/2006 | CN1742778A Cervus and cucumis polypeptide injection composition and preparing method |
| 03/08/2006 | CN1742775A Medicine composition for preventing and treating orthopedic diseases |
| 03/08/2006 | CN1742770A Chinese medicine for treating fractures and processing technology thereof |
| 03/08/2006 | CN1742769A Shuihema medicated liquor |
| 03/08/2006 | CN1742749A Gugua polypeptide medicinal composition for injetion and preparing method therefor |
| 03/08/2006 | CN1742746A Radix scutellariae total flavone extract and use of Radix scutellaride glucoside in preparing medicine for treating osteoporosis |
| 03/08/2006 | CN1742741A Medicinal composition containing amino glucose and calcium agent and vitamin D and use thereof |
| 03/08/2006 | CN1742736A Buckthorn extract, its preparing method and use in pharmaceutical process |
| 03/08/2006 | CN1742722A Method for resisting blood vessel generation |
| 03/08/2006 | CN1244580C Aminothiazoles and their use as adenosine receptor antagonists |
| 03/08/2006 | CN1244576C Chemical compounds |
| 03/08/2006 | CN1244574C Method for preparing water-soluble soybean aglycon and its applications |
| 03/08/2006 | CN1244561C Tetrahydroisoquinoline analogs useful as growth hormone secretagogues |
| 03/08/2006 | CN1244374C Pharmaceutical composition for treating rheumatism, rheumatoid arthritis and limb pains, and its preparation method |
| 03/08/2006 | CN1244369C Medicine for treating Sjogren syndrome and its preparing process |
| 03/08/2006 | CN1244364C Medicine for treating necrosis of femoral head |
| 03/08/2006 | CN1244347C Medicine for external application of treating osteoarthrosis |
| 03/08/2006 | CN1244342C Chinese prepared medicine for treating cervical spondylopathy |
| 03/07/2006 | US7009053 Quinoline derivatives as caspase-3 inhibitor, preparation for producing the same and pharmaceutical composition comprising the same |
| 03/07/2006 | US7009039 obtained by mixing plasma proteins fibrinogen and Factor XIII with thrombin and at least one anti-fibrinolytic agent (tranexamic acid) in absence of organic chelating agent; implant for tissue engineering |
| 03/07/2006 | US7008962 Interleukin-8 (IL-8); compounds such as 3-(2-hydroxy-phenylamino)-4-(2-bromophenylamino)-cyclobut-3-ene-1,2-dione for treating chemokine-mediated diseases such as autoimmune diseases, septic shock, graft versus host disease, allograft rejections |
| 03/07/2006 | US7008949 Antiinflammatory agents; antihistamines; Alzheimer's disease; anticholesterol agents; cardiovascular disorders; inflammatory bowel disorders; antitumor agents; antidiabetic agents; brain disorders; multiple sclerosis |
| 03/07/2006 | US7008946 CCR5 antagonists useful for treating AIDS |
| 03/07/2006 | US7008945 Amide derivatives |
| 03/07/2006 | US7008943 1-(Pyrrolidin-1-ylmethyl)-3-(pyrrol-2-ylmethylidene)-2-indolinone derivatives |
| 03/07/2006 | US7008938 Benzene-fused heteroring derivatives and pharmaceutical agents comprising the same as active ingredient |
| 03/07/2006 | US7008921 Materials and methods relating to endothelial cell growth inhibitors |
| 03/07/2006 | US7008640 Mixture of drug, aminoacrylate polymer and acid |
| 03/07/2006 | US7008613 technetium labelled complexes; for the treatment or diagnosis of pathologies caused by attack on human cartilage, arthritis |
| 03/02/2006 | WO2006023396A2 Vla-4 antagonists |
| 03/02/2006 | WO2006022442A1 Novel heterocyclic amide derivatives having dihydroorotate dehydrogenase inhibiting activity |
| 03/02/2006 | WO2006022374A1 2-phenylpyridine derivative |
| 03/02/2006 | WO2006022263A1 Medium for the redifferentiation of dedifferentiated chondrocytes into chondrocytes |
| 03/02/2006 | WO2006022234A1 NFATc1 EXPRESSION INHIBITOR, OSTEOCLAST DIFFERENTIATION OR ACTIVATION INHIBITOR, AND PHARMACEUTICAL COMPOSITION |
| 03/02/2006 | WO2006021660A1 Use of at least one conjugated triene-containing fatty acid for preparing a medicine for treating inflammation |
| 03/02/2006 | WO2006021418A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | WO2005019429A3 Compositions and methods for enhancing phagocytosis or phagocyte activity |
| 03/02/2006 | WO2003031464A3 Remodeling and glycoconjugation of peptides |
| 03/02/2006 | WO2002072769A3 Human serpin polypeptides |
| 03/02/2006 | DE60108394T2 Sulfonyl-pyrrolidinderivate geeignet für die behandlung von neurologischen krankheiten Sulfonyl-pyrrolidine derivatives suitable for the treatment of neurological diseases |
| 03/02/2006 | CA2578168A1 2-phenylpyridine derivative |
| 03/02/2006 | CA2577748A1 2-sulfanyl-benzoimidazol-1-yl-acetic acid derivatives as crth2 antagonists |
| 03/02/2006 | CA2576659A1 Solid and crystalline ibandronate sodium and processes for preparation thereof |
| 03/02/2006 | CA2576159A1 Purine and pyrimidine cdk inhibitors and their use for the treatment of autoimmune diseases |
| 03/02/2006 | CA2564898A1 Risedronate compositions and their methods of use |
| 03/01/2006 | EP1630162A1 2-aminoquinoline derivative |
| 03/01/2006 | EP1630157A1 CaSR ANTAGONIST |
| 03/01/2006 | EP1629832A1 A pharmaceutical formulation comprising human growth hormone, an amino acid and a non-ionic detergent |
| 03/01/2006 | EP1629012A1 Pharmaceutical compositions comprising bispecific anti-cd3, anti-cd19 antibody constructs for the treatment of b-cell related disorders |
| 03/01/2006 | EP1628994A2 Method for identifying modulators of g protein coupled receptor signaling |
| 03/01/2006 | EP1628968A1 4-imidazolin-2-one compounds |
| 03/01/2006 | EP1414426B1 Carbocyclic hydrazino inhibitors of copper-containing amine oxidases |
| 03/01/2006 | EP1363910B1 Methods of treating p38 kinase-associated conditions and pyrrolotriazine compounds useful as kinase inhibitors |
| 03/01/2006 | EP1347971B1 Thiazolyl inhibitors of tec family tyrosine kinases |
| 03/01/2006 | EP1339710B1 3-oxadiazol-5-yl-1-aminoalkyl-1h-indole derivatives |
| 03/01/2006 | EP1324774B1 Use of a ppar delta activator for treating inflammatory conditions |
| 03/01/2006 | EP1319007B1 Fused heterocyclic succinimide compounds and analogs thereof, modulators of nuclear hormone receptor function |
| 03/01/2006 | EP1311507B1 Fused pyrazole derivatives being protein kinase inhibitors |
| 03/01/2006 | EP1233962B1 Novel heterocyclic compounds and their use as medicines |
| 03/01/2006 | EP1162991B1 Arginine-rich anti-vascular endothelial growth factor peptides that inhibit growth and metastasis of human tumor cells by blocking angiogenesis |
| 03/01/2006 | EP1127355B1 Products and methods for brachytherapy |
| 03/01/2006 | EP0931148B1 Fibroblast growth factor homologs |
| 03/01/2006 | CN1741984A CaSR antagonist |
| 03/01/2006 | CN1741820A Nucleic acids, polypeptides, and methods for modulating apoptosis |
| 03/01/2006 | CN1741779A Improved formulations for transmucosal vaginal delivery of bisphosphonates |
| 03/01/2006 | CN1739799A Compound recipe for treating osteoarthrosis |
| 03/01/2006 | CN1739796A Slow release parathyroid hormone microballoon |
| 03/01/2006 | CN1739787A Orally administered peptides to ameliorate atherosclerosis |
| 03/01/2006 | CN1739772A Plaster and its prepn |
| 03/01/2006 | CN1739766A Traumatic injury treating medicine liquid |